03:50 PM EDT, 08/05/2026 (MT Newswires) -- Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each adding 1.2%.

The iShares Biotechnology ETF (IBB) increased 0.5%.

In corporate news, Eli Lilly ( LLY ) shares rose 4.7% after it posted higher Q2 non-GAAP earnings and revenue in addition to raising its 2026 sales guidance. Separately, CVS Health ( CVS ) said Wednesday it revamped its direct-to-consumer weight management program, lowering the cost of virtual visits and expanding access to GLP-1 medications through a collaboration with Lilly. CVS shares were down 3.8%.

Novo Nordisk ( NVO ) said Wednesday it won a preliminary injunction in the Netherlands against Ceban Ziekenhuisfarmacie in a patent-infringement case involving its compounded semaglutide nasal spray. Novo shares added 0.6%.

AstraZeneca ( AZN ) and Bristol Myers Squibb ( BMY ) are not engaged in discussions over a potential merger, Reuters reported Wednesday, citing a senior source close to the matter. AstraZeneca ( AZN ) shares rose 3.5%, and Bristol Myers Squibb ( BMY ) fell 3.2%.

Charles River Laboratories ( CRL ) on Wednesday reported fiscal Q2 non-GAAP earnings and sales above market expectations and raised its 2026 non-GAAP EPS guidance. Its shares jumped 11%.